Cryo-Cell International
CCEL
14 hedge funds and large institutions have $4.25M invested in Cryo-Cell International in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 0 closing their positions.
8% more funds holding
Funds holding: 13 → 14 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.62% less ownership
Funds ownership: 8.92% → 8.3% (-0.62%)
5% less capital invested
Capital invested by funds: $4.45M → $4.25M (-$209K)
80% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$118K |
| 2 |
Wells Fargo
San Francisco,
California
|
+$31 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ICM
ISZO Capital Management
New York
|
-$458K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$13.1K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$5.26K |
| 4 |
BlackRock
New York
|
-$2.06K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$814 |
CCEL Hedge Fund Activity: Q3 2022 in Review
14 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Cryo-Cell International (CCEL) for Q3 2022, worth a combined $4.25M — down 4.7% from $4.45M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new CCEL positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 5 trimmed.
The largest buyer was Geode Capital Management, opening a new position worth an estimated $118K. The largest seller was ISZO Capital Management, cutting an estimated $458K.
- 14 institutional investors held Cryo-Cell International (CCEL) as of Q3 2022, up from 13 in Q2 2022.
- Funds reported $4.25M of Cryo-Cell International stock for Q3 2022, down 4.7% quarter-over-quarter.
- 1 fund opened new Cryo-Cell International positions in Q3 2022 and 0 closed out, a net change of +1 holder.
- The largest Cryo-Cell International buyer in Q3 2022 was Geode Capital Management, an estimated $118K added.
- The largest Cryo-Cell International seller in Q3 2022 was ISZO Capital Management, an estimated $458K sold.
Based on aggregated 13F filings for Q3 2022.